Toshiharu Shimazaki - Concepedia

Author

Toshiharu Shimazaki

Taisho Pharmaceutical (Japan)

Also Known As

Toshiharu SHIMAZAKI, Toshiharu Shimazaki, Toshiharu Shimazaki Toshiharu Shimazaki

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)

About

Toshiharu Shimazaki is an author at Taisho Pharmaceutical (Japan) specializing in neuropharmacology, medicine, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1K
2	Social Sciences	13	13	1.1K
3	Natural Sciences	1	1	43
4	Behavioral Sciences	1	1	36
5	Biochemistry	1	1	43

Toshiharu Shimazaki

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota, Neuropharmacology Antidepressant-like ActivityPsychoactive DrugPsychiatryFunctional SelectivityMedicine	2003	250
Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists Shigeyuki Chaki, Takeo Funakoshi, Shiho Hirota-Okuno, Journal of Pharmacology and Experimental Therapeutics	2005	132
An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats Takao Yoshimizu, Toshiharu Shimazaki, Akie Ito, Psychopharmacology Psychoactive DrugPsychiatryBehavioral NeuroscienceMedicinePsychotropic Medication	2006	131
AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist Jun-ichi Karasawa, Toshiharu Shimazaki, Naoya Kawashima, Brain Research PsychiatryNeurophysiologyMedicineFunctional SelectivityNeurotransmitter	2005	130
Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents Shigeyuki Chaki, Naoya Kawashima, Yoshiko Suzuki, European Journal of Pharmacology Substance AbusePsychoactive DrugBehavioral NeuroscienceAddictionAmphetamine-regulated Transcript Peptide	2003	97
d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats Toshiharu Shimazaki, Ayaka Kaku, Shigeyuki Chaki Psychopharmacology Cognitive ScienceBrain FunctionBehavioral NeuroscienceNeurobiological FactorNeurotransmitter	2010	82
Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test Toshiharu Shimazaki, Michihiko Iijima, Shigeyuki Chaki European Journal of Pharmacology NeuropsychologyPsychoactive DrugAnxiolytic-like ActivityPsychiatryBehavioral Neuroscience	2004	75
The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats Toshiharu Shimazaki, Michihiko Iijima, Shigeyuki Chaki European Journal of Pharmacology NeuropsychologySocial Interaction TestStress HormonePsychiatryBehavioral Neuroscience	2006	75
Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors Naoya Kawashima, Jun-ichi Karasawa, Toshiharu Shimazaki, Neuroscience Letters NeurophysiologyMedicineFunctional SelectivityNeuropeptide ReceptorNeuropharmacology	2005	65
Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): A potent and orally active group II mGluR antagonist with antidepressant-like potential Akito Yasuhara, Masato Nakamura, Kazunari Sakagami, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesPsychotropic Medication	2006	43

Page 1